COVID-19

The Food and Drug Administration had urged Pfizer and its partner BioNTech to apply for authorization of extra-low doses of its vaccine for the youngest children before studies were even finished—citing the toll the Omicron variant has taken on children.

Report says expanded scope of practice during pandemic helps patients.

Its shots have been cleared for use in adults by regulators in Britain, Europe and elsewhere and by the World Health Organization, and are under review by the U.S. Food and Drug Administration.

Take our weekly news poll and see what other doctors say about this issue.

Two years into the COVID-19 pandemic, Dr. Dalhia Chiche-More, knows that one day this will all be over but she wonders if medicine will ever be the same again?

In the spirit of Valentine’s Day—and all things love this February—we asked some pharmacist couples to share the story of their love connection

In a scathing decision that takes aim at basic anti-vaccination arguments, Court of Queen's Bench Justice E. Thomas Christie said the court had no jurisdiction in this case.